304174242	304174242	CD	B-NP	O
|	|	NN	I-NP	O
VUH	VUH	NN	I-NP	O
|	|	NN	I-NP	O
77984471	77984471	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4166299	4166299	CD	B-NP	O
|	|	CC	I-NP	O
8/17/2006	8/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2006	10/11/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2006	1/9/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WATERFALL	WATERFALL	NNP	B-NP	O
,	,	,	O	O
SAMMY	SAMMY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Team	Team	NNP	I-NP	O
He	He	NNP	I-NP	O
Drive	Drive	NNP	I-NP	O
,	,	,	O	O
Ville	Ville	NNP	B-NP	O
Sas	Sas	NNP	I-NP	O
Oaksco	Oaksco	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Quigg	Quigg	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42-year-old	42-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
Charcot	Charcot	NNP	B-NP	O
foot	foot	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
recall	recall	VB	I-VP	O
having	have	VBG	I-VP	O
fevers	fever	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
``	``	``	O	O
get	get	VB	B-VP	O
fevers	fever	NNS	B-NP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
time	time	NN	I-NP	O
''	''	''	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
noticed	notice	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
to	to	TO	B-PP	O
about	about	RB	B-NP	O
101	101	CD	I-NP	O
and	and	CC	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
joint	joint	JJ	B-NP	O
aches	ache	NNS	I-NP	O
or	or	CC	O	O
rash	rash	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
endorse	endorse	NN	B-NP	O
feeling	feeling	NN	I-NP	O
fatigued	fatigue	VBN	B-VP	O
with	with	IN	B-PP	O
little	little	JJ	B-NP	O
energy	energy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
Charcot	Charcot	VB	I-VP	O
joint	joint	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
recurrent	recurrent	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
numerous	numerous	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
to	to	TO	B-PP	O
SMC	SMC	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
foot	foot	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
several	several	JJ	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
from	from	IN	B-PP	O
10/5	10/5	CD	B-NP	O
through	through	IN	B-PP	O
10/24	10/24	CD	B-NP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
posthemodialysis	posthemodialysis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
10/24	10/24	CD	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
returning	return	VBG	B-VP	O
from	from	IN	B-PP	O
weekend	weekend	NN	B-NP	O
away	away	RB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
swelling	swell	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bottom	bottom	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
including	include	VBG	B-PP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
foot	foot	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
for	for	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
from	from	IN	B-PP	O
1/18	1/18	CD	B-NP	O
through	through	IN	B-PP	O
5/22	5/22	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
or	or	CC	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
also	also	RB	B-VP	O
reports	report	VBZ	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
without	without	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
for	for	IN	B-PP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
consequent	consequent	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nephropathy	nephropathy	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	B-protein
since	since	IN	B-PP	I-protein
7/17	7/17	CD	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
Charcot	Charcot	NNP	B-NP	O
feet	foot	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
fourth	fourth	JJ	B-NP	O
metatarsal	metatarsal	JJ	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
with	with	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
resection	resection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
digit	digit	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Retinopathy	Retinopathy	NN	B-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
retinal	retinal	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
and	and	CC	I-NP	O
vitrectomy	vitrectomy	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
x19	x19	CD	B-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
with	with	IN	B-PP	O
documented	document	VBN	B-NP	O
ophthalmologic	ophthalmologic	JJ	I-NP	O
and	and	CC	I-NP	O
renal	renal	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
2001	2001	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Renagel	Renagel	NNP	B-NP	O
3200	3200	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Requip	Requip	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
ALLERGIES	ALLERGIES	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
parents	parent	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
12-year-old	12-year-old	JJ	I-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
100.8	100.8	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
111	111	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
140/70	140/70	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
with	with	IN	B-PP	O
erythema	erythema	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
shin	shin	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
warmth	warmth	NN	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Radiology	Radiology	NN	B-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
9/10/06	9/10/06	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
MRI	MRI	NN	I-NP	O
LE	LE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
10/23/06	10/23/06	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
cm	cm	NN	I-NP	O
fluid	fluid	NN	I-NP	O
pocket	pocket	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
communication	communication	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
tendon	tendon	NN	I-NP	O
sheaths	sheath	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ankle	ankle	NN	I-NP	O
joint	joint	NN	I-NP	O
with	with	IN	B-PP	O
findings	finding	NNS	B-NP	O
worrisome	worrisome	VBP	B-VP	O
for	for	IN	B-PP	O
abscess	abscess	NN	B-NP	O
and	and	CC	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
malleolus	malleolus	NN	I-NP	O
,	,	,	I-NP	O
calcaneus	calcaneus	NN	I-NP	O
,	,	,	I-NP	O
cuboid	cuboid	NN	I-NP	O
and	and	CC	I-NP	O
talus	talus	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
LFTs	LFT	NNS	B-NP	O
:	:	:	O	O
WNL	WNL	NNP	B-NP	O
Alb	Alb	NNP	I-NP	O
2.8	2.8	CD	I-NP	O
ESR	ESR	NNP	I-NP	O
75	75	CD	I-NP	O
,	,	,	I-NP	O
CRP	CRP	NN	I-NP	O
276	276	CD	I-NP	O
Hep	Hep	NN	I-NP	O
B	B	NN	I-NP	O
surf	surf	NN	I-NP	O
Ag	Ag	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
HCV	HCV	NN	B-NP	B-protein
Ab	Ab	NN	I-NP	I-protein
negative	negative	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2/22/06	2/22/06	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Micro	Micro	NNP	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
cx	cx	NN	I-NP	O
1/12/7	1/12/7	CD	I-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
growth	growth	NN	I-NP	O
Foot	Foot	NN	I-NP	O
aspirate	aspirate	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
2/22/06	2/22/06	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
gram	gram	NN	B-NP	B-protein
stain-2	stain-2	NN	I-NP	I-protein
+	+	SYM	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
org	org	NN	I-NP	O
;	;	:	O	O
Cx	Cx	NN	B-NP	O
without	without	IN	B-PP	O
growth	growth	NN	B-NP	B-protein
Ankle	Ankle	NN	I-NP	I-protein
aspirate	aspirate	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2/22/06	2/22/06	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
gm	gm	NN	B-NP	B-protein
stain-4	stain-4	NN	I-NP	I-protein
+	+	SYM	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
org	org	NN	I-NP	O
;	;	:	O	O
Cx	Cx	NN	B-NP	O
without	without	IN	B-PP	O
growth	growth	NN	B-NP	O
Pathology	Pathology	NN	I-NP	O
from	from	IN	B-PP	O
L	L	NN	B-NP	B-protein
BKA	BKA	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
1/3/06	1/3/06	CD	B-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
-	-	HYPH	I-NP	O
clean	clean	JJ	I-NP	O
margins	margin	NNS	I-NP	O
CONSULTS	CONSULTS	NNS	I-NP	O
:	:	:	O	O
Orthopedics	Orthopedics	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Bourgault	Bourgault	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
ID	ID	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Antinoro	Antinoro	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Psychiatry	Psychiatry	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Czach	Czach	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Acute	Acute	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID-Given	ID-Given	JJ	B-VP	O
his	his	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
lower	low	JJR	I-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Bock	Bock	NNP	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
Unasyn	Unasyn	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
X-ray	X-ray	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
L	L	NN	I-NP	O
foot	foot	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
significant	significant	JJ	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
and	and	CC	I-NP	O
erosion	erosion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tarsal/metatarsal	tarsal/metatarsal	NN	I-NP	O
bases	base	NNS	I-NP	O
and	and	CC	O	O
focal	focal	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
abscess	abscess	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
Charcot	Charcot	NNP	I-NP	O
arthropathy	arthropathy	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
diffuse	diffuse	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
swelling	swell	VBG	B-VP	O
extending	extend	VBG	B-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
calf	calf	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
.	.	.	O	O

With	With	IN	B-PP	O
his	his	PRP$	B-NP	O
MRI	MRI	NN	I-NP	B-protein
pending	pende	VBG	B-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
L	L	NN	I-NP	O
leg	leg	NN	I-NP	O
looking	look	VBG	B-VP	O
somewhat	somewhat	RB	I-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Unasyn	Unasyn	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Augmentin	Augmentin	NNP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
spiked	spike	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
and	and	CC	O	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
under	under	IN	B-PP	O
conscious	conscious	JJ	B-NP	O
sedation	sedation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

MRI	MRI	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
4	4	CD	B-NP	O
cm	cm	NN	I-NP	O
fluid	fluid	NN	I-NP	O
pocket	pocket	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
communication	communication	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
tendon	tendon	NN	I-NP	O
sheaths	sheath	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ankle	ankle	NN	I-NP	O
joint	joint	NN	I-NP	O
with	with	IN	B-PP	O
findings	finding	NNS	B-NP	O
worrisome	worrisome	VBP	B-VP	O
for	for	IN	B-PP	O
abscess	abscess	NN	B-NP	O
and	and	CC	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
malleolus	malleolus	NN	I-NP	O
,	,	,	I-NP	O
calcaneus	calcaneus	NN	I-NP	O
,	,	,	I-NP	O
cuboid	cuboid	NN	I-NP	O
and	and	CC	I-NP	O
talus	talus	NN	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
gram	gram	NN	B-NP	O
negatives	negative	NNS	I-NP	O
and	and	CC	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dosed	dose	VBN	I-VP	O
for	for	IN	B-PP	O
level	level	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
who	who	WP	B-NP	O
performed	perform	VBD	B-VP	O
an	an	DT	B-NP	O
arthrocentesis	arthrocentesis	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
ankle	ankle	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
arthrocentesis	arthrocentesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bottom	bottom	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Ankle	Ankle	JJ	B-NP	O
aspirate	aspirate	NN	I-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
polys	poly	NNS	I-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
differential	differential	JJ	I-NP	O
revealed	reveal	VBD	B-VP	O
>	>	JJR	B-NP	O
160	160	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
WBCs	WBC	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
orthopedics	orthopedic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
L	L	NN	I-NP	O
below	below	IN	B-PP	O
knee	knee	NN	B-NP	O
amputation	amputation	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Miears	Miears	NNP	I-NP	O
He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
fever	fever	NN	B-NP	O
spikes	spike	NNS	I-NP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
8-9	8-9	CD	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
repeat	repeat	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
tiny	tiny	JJ	I-NP	O
focal	focal	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
cusp	cusp	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
with	with	IN	B-PP	O
Cardiology	Cardiology	NN	B-NP	O
and	and	CC	O	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
though	though	IN	B-SBAR	O
to	to	TO	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
x	x	SYM	O	O
>	>	SYM	O	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
surgical	surgical	JJ	I-NP	O
pathology	pathology	NN	I-NP	O
returned	return	VBD	B-VP	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
margins	margin	NNS	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
ID	ID	NN	B-NP	O
consult	consult	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
further	further	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
dry	dry	JJ	B-NP	O
sterile	sterile	JJ	I-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
residual	residual	JJ	I-NP	O
limb	limb	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
an	an	DT	B-NP	O
extra	extra	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
medication	medication	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
or	or	CC	I-NP	O
drainage	drainage	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Fuller	Fuller	NNP	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
at	at	IN	B-PP	O
365-299-5817	365-299-5817	CD	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal-Mr	Renal-Mr	NNP	I-NP	O
.	.	.	O	O

Merriweather	Merriweather	NN	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
M/W/F	M/W/F	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
awaiting	await	VBG	I-VP	O
kidney	kidney	NN	B-NP	O
transplant	transplant	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Felix	Felix	NNP	I-NP	O
Zelle	Zelle	NNP	I-NP	O
at	at	IN	B-PP	O
NNH	NNH	NNP	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme-Mr	Heme-Mr	NNP	I-NP	O
Vaeth	Vaeth	NNP	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
records	record	NNS	I-NP	O
from	from	IN	B-PP	O
NUOM	NUOM	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
study	study	NN	I-NP	O
from	from	IN	B-PP	O
9/19	9/19	CD	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
DVT	DVT	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
L	L	NN	I-NP	O
internal	internal	JJ	I-NP	O
jugular	jugular	JJ	I-NP	O
vein	vein	NN	I-NP	O
from	from	IN	B-PP	O
5/5	5/5	CD	B-NP	O
The	The	DT	B-NP	O
details	detail	NNS	I-NP	O
surrounding	surround	VBG	B-VP	O
this	this	DT	B-NP	O
DVT	DVT	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
documented	document	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
Mr.	Mr.	NNP	B-NP	O
Tirona	Tirona	NNP	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
told	tell	VBD	B-VP	O
him	him	PRP	B-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
BKA	BKA	NN	I-NP	B-protein
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
bridged	bridge	VBN	I-VP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
60-80	60-80	CD	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
PTT	PTT	NNP	B-NP	O
was	be	VBD	B-VP	O
103	103	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
2100	2100	CD	B-NP	O
to	to	TO	B-PP	O
1950units	1950unit	NNS	B-NP	O
per	per	IN	B-PP	O
hours	hour	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
PTT	PTT	NN	I-NP	O
checked	check	VBN	B-VP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
center	center	NN	I-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
PTT	PTT	NN	I-NP	O
60-80	60-80	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
1.6	1.6	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heparin	heparin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
once	once	RB	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
every	every	DT	B-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
stable	stable	JJ	B-NP	O
off	off	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CV	CV	NNP	I-NP	O
Ischemia-Mr	Ischemia-Mr	NNP	I-NP	O
Grana	Grana	NNP	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600mg	600mg	NN	I-NP	O
bid	bid	NN	I-NP	O
and	and	CC	O	O
lipitor	lipitor	NN	B-NP	O
80mg	80mg	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
:	:	:	O	O
TC	TC	NN	B-NP	B-protein
140	140	CD	I-NP	I-protein
,	,	,	O	O
TG	TG	NN	B-NP	B-protein
151	151	CD	I-NP	I-protein
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
82	82	CD	I-NP	I-protein
,	,	,	O	O
HDL	HDL	NN	B-NP	O
28	28	CD	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
LDL	LDL	NN	I-NP	B-protein
was	be	VBD	B-VP	O
82	82	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
rhabdomylosis	rhabdomylosis	NN	B-NP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
gemfibrozil	gemfibrozil	NN	I-NP	O
and	and	CC	I-NP	O
lipitor	lipitor	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
lipitor	lipitor	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
20mg	20mg	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
in	in	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
b-blocker	b-blocker	NN	I-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
perioperative	perioperative	JJ	B-NP	O
MI	MI	NN	I-NP	O
risk	risk	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
b/l	b/l	NN	B-NP	O
vitrectomies	vitrectomy	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleeding	NN	B-NP	O
was	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
readdressed	readdresse	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Pump-Pt	Pump-Pt	NN	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
160s	160	NNS	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
uptitrated	uptitrate	VBN	I-VP	O
to	to	TO	B-PP	O
5mg	5mg	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
lopressor	lopressor	NN	B-NP	O
.	.	.	O	O

Rhtyhm-He	Rhtyhm-He	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
arrythmias	arrythmia	NNS	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrine-Mr	Endocrine-Mr	NNP	I-NP	O
.	.	.	O	O

Rovella	Rovella	NNP	B-NP	O
has	have	VBZ	B-VP	O
DM	DM	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
or	or	CC	I-NP	O
II	II	CD	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
Type	Type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
year	year	NN	I-NP	O
stint	stint	NN	I-NP	O
after	after	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
FS	FS	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
lantus	lantus	NN	I-NP	O
was	be	VBD	B-VP	O
uptitrated	uptitrate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prandial	prandial	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Aspart	Aspart	NNP	B-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
already	already	RB	B-ADVP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
with	with	IN	B-PP	O
whom	whom	WP	B-NP	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

An	An	DT	B-NP	O
HgA1c	HgA1c	NN	I-NP	B-protein
was	be	VBD	B-VP	O
8.4	8.4	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pain-Mr	Pain-Mr	NNP	I-NP	O
.	.	.	O	O

Vanhee	Vanhee	NNP	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
post	post	NN	I-NP	O
operative	operative	JJ	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mostly	mostly	RB	B-NP	O
phantom	phantom	JJ	I-NP	O
limb	limb	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
acute	acute	JJ	I-NP	O
pain	pain	NN	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
ketamine	ketamine	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
Fentanyl	Fentanyl	NN	B-NP	O
PCA	PCA	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
PCA	PCA	NN	I-NP	O
and	and	CC	O	O
ketamine	ketamine	NN	B-NP	O
drip	drip	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
oxycontin	oxycontin	NN	B-NP	O
80mg	80mg	CD	I-NP	O
tid	tid	NN	I-NP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lyrica	Lyrica	NNP	B-NP	O
for	for	IN	B-PP	O
neuropathic	neuropathic	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
current	current	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
improves	improve	VBZ	B-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
pain	pain	VBP	B-VP	O
regimen	regimen	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Psychiatry-After	Psychiatry-After	NN	I-NP	O
learning	learn	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
likely	likely	RB	I-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Potvin	Potvin	NNP	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
significant	significant	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
going	go	VBG	B-VP	O
for	for	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
Ativan	Ativan	NNP	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
him	him	PRP	B-NP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Gen	Gen	NN	B-NP	O
:	:	:	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
well	well	RB	B-ADVP	O
appearing	appear	VBG	B-VP	O
gentleman	gentleman	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
VS	VS	NN	I-NP	O
:	:	:	O	O
Tmax	Tmax	NN	B-NP	O
:	:	:	O	O
98.5	98.5	CD	B-NP	O
Tc	Tc	NN	I-NP	O
:	:	:	O	O
97.6	97.6	CD	B-NP	O
BP	BP	NN	I-NP	O
122-144	122-144	CD	B-NP	O
/	/	SYM	I-NP	O
70-80	70-80	CD	I-NP	O
P	P	NN	I-NP	O
74-84	74-84	CD	B-NP	O
R	R	NN	I-NP	O
18	18	CD	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
Pulm	Pulm	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
rales/wheezes	rales/wheeze	VBZ	B-VP	O
CV	CV	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
at	at	IN	B-PP	O
LSB	LSB	NNP	B-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1/S2	S1/S2	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
NABS	NABS	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
residual	residual	JJ	I-NP	O
limb	limb	NN	I-NP	O
with	with	IN	B-PP	O
dressing	dress	VBG	B-VP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
clean/dry/intact	clean/dry/intact	JJ	B-NP	O
LABS	LABS	NN	I-NP	O
ON	ON	NN	I-NP	O
DAY	DAY	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
dialysis	dialysis	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Na	Na	NN	I-NP	O
136	136	CD	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
4.5	4.5	CD	I-NP	I-cell_line
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
6.0	6.0	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
7.6	7.6	CD	I-NP	I-cell_line
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
28.6	28.6	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.8	1.8	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
103	103	CD	I-NP	O
TO	TO	NN	I-NP	O
DO	DO	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
dry	dry	JJ	I-NP	O
sterile	sterile	JJ	I-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
L	L	NN	B-NP	O
residual	residual	JJ	I-NP	O
limb	limb	NN	I-NP	O
daily	daily	JJ	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
drainage	drainage	NN	B-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
contact	contact	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Mcclain	Mcclain	NNP	I-NP	O
?	?	.	O	O
?	?	.	O	O
?	?	.	O	O
s	s	JJ	B-NP	O
office	office	NN	I-NP	O
at	at	IN	B-PP	O
323-734-0631	323-734-0631	CD	B-NP	O
-	-	HYPH	I-NP	O
check	check	NN	I-NP	O
PTT	PTT	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
PTT	PTT	NN	I-NP	O
60-80	60-80	CD	I-NP	O
;	;	:	O	O
can	can	MD	B-VP	O
d/c	d/c	VB	I-VP	O
heparin	heparin	NN	B-NP	O
once	once	RB	B-ADJP	O
INR	INR	NN	I-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
at	at	IN	B-PP	O
2-3	2-3	CD	B-NP	O
-	-	HYPH	I-NP	O
daily	daily	JJ	I-NP	O
INR	INR	NN	I-NP	O
until	until	IN	B-PP	O
stable	stable	JJ	B-NP	O
at	at	IN	B-PP	O
goal	goal	NN	B-NP	B-protein
2-3	2-3	CD	I-NP	I-protein
off	off	RP	B-PRT	I-protein
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
;	;	:	O	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
titrate	titrate	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
-	-	HYPH	B-NP	O
monitor	monitor	NN	I-NP	O
FS	FS	NN	I-NP	O
and	and	CC	O	O
adjust	adjust	JJ	B-NP	O
DM	DM	NN	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
-	-	HYPH	I-NP	O
monitor	monitor	NN	I-NP	O
pain	pain	NN	I-NP	O
scale	scale	NN	I-NP	O
and	and	CC	O	O
decrease	decrease	VB	B-VP	O
pain	pain	NN	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
pain	pain	NN	B-NP	O
improves	improve	VBZ	B-VP	O
-	-	HYPH	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
M/W/F	M/W/F	NN	I-NP	O
FOLLOW	FOLLOW	NN	I-NP	O
UP	UP	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Carpino	Carpino	NNP	I-NP	O
voice	voice	NN	I-NP	O
message	message	NN	I-NP	O
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_type
medical	medical	JJ	I-NP	I-cell_type
assistant	assistant	NN	I-NP	I-cell_type
?	?	.	O	I-cell_type
?	?	.	O	O
?	?	.	O	O
s	s	JJ	B-NP	O
voice	voice	JJ	I-NP	O
mail	mail	NN	I-NP	O
at	at	IN	B-PP	O
323-734-0631	323-734-0631	CD	B-NP	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
pt	pt	NN	B-NP	O
?	?	.	O	O
?	?	.	O	O
?	?	.	O	O
s	s	JJ	B-NP	O
parents	parent	NNS	I-NP	O
to	to	TO	B-VP	O
arrange	arrange	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appt	appt	NN	B-NP	O
in	in	IN	B-PP	O
7-10	7-10	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
check	check	NN	I-NP	O
-	-	HYPH	O	O
Dr.	Dr.	NNP	B-NP	O
Lynes	Lynes	NNP	I-NP	O
2/23/06	2/23/06	CD	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	B-NP	O
30	30	CD	I-NP	O
am	am	NN	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-8336937	5-8336937	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
AGTARAP	AGTARAP	NN	B-NP	O
,	,	,	O	O
GUADALUPE	GUADALUPE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CARMIN	CARMIN	NNP	B-NP	O
,	,	,	O	O
MARLIN	MARLIN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3872938	3872938	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/18/06	1/18/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/18/06	1/18/06	CD	B-NP	O

